Endocrine Technologies Company Profile

05:57 EDT 21st September 2018 | BioPortfolio

Welcome to Endocrine Technologies Located in the San Francisco Bay Area, Endocrine Technologies is dedicated to research, development, manufacture and distribution of innovative new scientific discovery tools, diagnostic products and therapies for researchers and physicians in both human healthcare and veterinary healthcare. Our focus is to develop new innovative diagnostic tools and therapies to diagnose and treat infectious diseases around the globe...including malaria, Leishmania, TB, Dengue, EPM and West Nile virus. Our satisfied customers include universities, laboratories, veterinary clinics, and major corporations across the globe.


35325 Fircrest Street,
United States of America


Phone: 1.510.745.0844
Fax: 1.510.745.0977

News Articles [443 Associated News Articles listed on BioPortfolio]

Endocrine Manifestations of Primary Hyperoxaluria

What endocrine disturbances are associated with this rare metabolic disease? Endocrine Practice

2017 AACE/Endocrine Society Update on Transgender Medicine

These cases provide key teaching points regarding the endocrine care of transgender patients. Endocrine Practice

Top takeaways from ENDO 2018

Endocrine Today has compiled a list of the top five news stories posted from the Endocrine Society Annual Meeting, held March 17–20 in readers were interested in ess...

Endocrine Society awards inaugural Baxter Prize to women's health entrepreneur

(The Endocrine Society) French physician and researcher André Ulmann, M.D., Ph.D., won the Endocrine Society's first-ever John D. Baxter Prize for Entrepreneurship for his advances in women's health ...

Endocrine Society touts global diversity, achievements in opening address

Lynette K. NiemanCHICAGO — The Endocrine Society celebrated a year of international growth and accomplishment in 2017, including the expansion of several key initiatives and increased advocacy effor...

Pediatric Cancer Survivors Need Lifelong Endocrine Screening

(MedPage Today) -- New Endocrine Society clinical practice guidelines

Endocrine Society launches podcast spotlighting breakthroughs in hormone science

(The Endocrine Society) International experts delve into the latest advances in hormone research and clinical care on the Endocrine Society's new podcast, which launches today.

Expert Highlights Incorporation of Neoadjuvant Endocrine Therapy Into ER+ Breast Cancer

Hung T. Khong, MD, discusses the benefits of neoadjuvant endocrine therapy and addresses the use of adjuvant endocrine therapy in ER-positive breast cancer.

PubMed Articles [752 Associated PubMed Articles listed on BioPortfolio]

Tweets and Transformative Technologies: Enabling Our Endocrine Future.

ER-positive breast cancer cells are poised for RET-mediated endocrine resistance.

The RET tyrosine kinase signaling pathway is involved in the development of endocrine resistant ER+ breast cancer. However, we know little about how ER+ cells activate RET signaling and initiate an en...


Endocrine tumor markers (ETMs) are important and indispensable tools in the diagnosis and follow-up of endocrine tumors. Unexpectedly high level of ETM (UHLETM) is often encountered in clinical practi...

65 YEARS OF THE DOUBLE HELIX: It's all in the DNA: understanding and managing endocrine neoplasms.

Successful management of multiple-systemic Langerhans cell histiocytosis involving endocrine organs in an adult: A case report and review of literature.

Langerhans cell histiocytosis (LCH) involving non-endocrine organs has been frequently reported, whereas LCH involving endocrine organs is rare and the mechanism is unclear.

Clinical Trials [878 Associated Clinical Trials listed on BioPortfolio]

Registry of Endocrine Tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube)

This registry aims to collect informations about patients with endocrine tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube) who undergo endocrine surgical...

Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

This trial studies the effects on quality of life and on time to second progression of the sequence endocrine therapy-capecitabine versus the sequence capecitabine-endocrine treatment. It ...

Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy

The purpose of this study is to evaluate radiotherapy followed by endocrine therapy in comparison with endocrine therapy alone for PSA failure after radical prostatectomy.

A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting.

The goal of the study for patients with metastatic breast cancer (MBC) is to show that palbociclib + endocrine therapy shows a significant improvement in time-to-treatment failure over che...

Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

This research study is evaluating how well Breast Cancer responds to preoperative treatment with Endocrine treatment in combination with a drug called Palbociclib or Endocrine treatment al...

Companies [1297 Associated Companies listed on BioPortfolio]

Endocrine Technologies

Welcome to Endocrine Technologies Located in the San Francisco Bay Area, Endocrine Technologies is dedicated to research, development, manufacture and distribution of innovative new scientific discove...

Neurocrine Biosciences

Neurocrine Biosciences is a leading neuroscience company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases...

Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in t...

Endocrine Technology, L.L.C.

Crinetics Pharmaceuticals

Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of specialty endocrine disorders in neuroendocrinology, r...

More Information about "Endocrine Technologies" on BioPortfolio

We have published hundreds of Endocrine Technologies news stories on BioPortfolio along with dozens of Endocrine Technologies Clinical Trials and PubMed Articles about Endocrine Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Endocrine Technologies Companies in our database. You can also find out about relevant Endocrine Technologies Drugs and Medications on this site too.

Quick Search


Relevant Topics

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record